Close Menu

NEW YORK — TNG Dx said on Tuesday that it has partnered with Premier Medical Laboratories to develop a rapid RNA extraction protocol for use with SARS-CoV-2 diagnostics.

TNG Dx, a New York City-based startup focused on SARS-CoV-2 test and technology distribution, said that it has collected over 500 paired saliva samples using anterior nasal sampling at the Harris Country testing site near Houston, Texas.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.